Company Galapagos NV

Equities

GLPG

BE0003818359

Biotechnology & Medical Research

Market Closed - Euronext Amsterdam 12:37:14 2024-03-28 pm EDT After market 01:55:04 pm
29.58 EUR -2.50% Intraday chart for Galapagos NV 29.66 +0.29%

Business Summary

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. The company is committed to improving patients' lives worldwide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan.

Number of employees: 1,338

Sales per Business

EUR in Million2021Weight2022Weight Delta
Small Molecules and Cell Therapies
100.0 %
485 100.0 % 505 100.0 % +4.21%

Sales per region

EUR in Million2021Weight2022Weight Delta
United States
82.0 %
468 99.6 % 414 82.0 % -11.51%
Europe
18.0 %
2 0.4 % 91 18.0 % +4,211.78%

Managers

Managers TitleAgeSince
Chief Executive Officer 62 22-03-31
Director of Finance/CFO 54 23-06-30
Investor Relations Contact - 20-10-31
General Counsel - 22-07-31
Human Resources Officer - 17-12-31
Corporate Secretary - -
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 66 22-04-25
Director/Board Member 65 23-09-18
Director/Board Member 61 19-10-21
Chief Executive Officer 62 22-03-31
Director/Board Member 57 23-06-11
Director/Board Member 61 19-04-29
Director/Board Member 63 20-04-27
Director/Board Member - 22-04-25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 65,897,071 49,160,074 ( 74.60 %) 0 74.60 %

Shareholders

NameEquities%Valuation
16,707,477 25.35 % 595 M €
Van Herk Investments BV
7.035 %
4,635,672 7.035 % 165 M €
CAPFI DELEN Asset Management NV
0.2706 %
178,305 0.2706 % 6 M €
De Grote Voskuil Capital BV
0.2352 %
155,000 0.2352 % 6 M €
FundQuest Advisor
0.2230 %
146,941 0.2230 % 5 M €
Goldman Sachs Advisors BV
0.2170 %
143,000 0.2170 % 5 M €
Econopolis Wealth Management NV
0.1214 %
80,000 0.1214 % 3 M €
Dimensional Fund Advisors Ltd.
0.1129 %
74,417 0.1129 % 3 M €
Allianz Global Investors GmbH (Netherlands)
0.1124 %
74,100 0.1124 % 3 M €
OP Asset Management Ltd.
0.0986 %
65,000 0.0986 % 2 M €
NameEquities%Valuation
EcoR1 Capital, LLC
8.735 %
5,756,268 8.735 % 202 M €
Fidelity Management & Research Co. LLC
6.425 %
4,233,803 6.425 % 149 M €
BVF, Inc.
2.906 %
1,915,109 2.906 % 67 M €
Segall Bryant & Hamill LLC
1.327 %
874,728 1.327 % 31 M €
Prosight Management LP
1.255 %
827,294 1.255 % 29 M €
PRIMECAP Management Co.
1.030 %
678,877 1.030 % 24 M €
Deerfield Management Co. LP (Private Equity)
0.9441 %
622,112 0.9441 % 22 M €
Wellington Management Co. LLP
0.7515 %
495,217 0.7515 % 17 M €
Finepoint Capital LP
0.6960 %
458,659 0.6960 % 16 M €
BlackRock Advisors LLC
0.6857 %
451,880 0.6857 % 16 M €

Company contact information

Galapagos NV

Industriepark Mechelen Noord Generaal de Wittelaan L11 A3

2800, Mechelen

+32 1 534 29 00

http://www.glpg.com
address Galapagos NV(GLPG)